Evofem Reports Results, Readies Product For September Debut

PHARMACEUTICALS: FDA Approved New Form of Birth Control in May

ProciseDx Raises $10.5M In Series A

BIOTECH: Co. Making Progress in Gastrointestinal Tests

Tease photo

Aethlon Medical Receives $3.5M NIH Grant

Aethlon Medical has been awarded a grant ($3.5 million) for studies in head and neck cancer.

La Jolla Institute Gets $1M Gift for COVID Research

La Jolla Institute for Immunology received a $1 million gift to further its work in COVID-19 research. The GHR Foundation, an independent philanthropy based in Minneapolis, made the gift, announced on Aug. 4.

BioAtla Raises $72.5M Series D Round Led By Soleus Capital

BIOTECH: Co. Has Two Drugs In Clinical Trials With Plans to Expand

Phamatech Signs Deal with Broward County School

Phamatech will provide on-site sample collection at six school district locations that will then be sent to Phamatech’s laboratory in San Diego for analysis.

Arcturus Therapeutics Makes Case for Experimental RNA-Based COVID-19 Vaccine

BIOTECH: Receives Greenlight on Phase 1/2 of Clinical Trials

Truvian Gains EUA Approval From FDA

Truvian Sciences has received federal emergency approval for its COVID-19 antibodies.

Arcturus Moves Forward With COVID-19 Vaccine Clinical Trial

San Diego-based Arcturus Therapeutics Inc. announced its vaccine has been approved to proceed with Phase 1/2 Clinical Trial

Transplant Games Slated for Summer 2022

San Diego will host the Donate Life Transplant Games 24 months from now. The San Diego County Credit Union Holiday Bowl organization led the successful bid to bring the games to San Diego.

Industry Veterans Start New Company, Raise $78M For Cell-Based Cancer Therapies

BIOTECH: Artiva Biotherapeutics to Start Clinical Trials This Year

Illumina Software Buy Estimated At $100 Million

GENOMICS: Deal Seen as Widening Competitive Edge

Hotels, Salons, Hospitals Turn to Powerful Light to Disinfect and Sanitize

SAFETY: Local Companies Find New Ways to Fight COVID-19

Tease photo

Acadia Submits New Drug Application to FDA

Acadia Pharmaceuticals has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration.

Artiva Biotherapeutics Launches with $78M Series A Financing

Artiva is advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, including CAR-NK cell therapies